Drug profile · INN
dimethyl fumarate
DIMHERITY
- US status
- approved
- Patents linked
- 1
- News articles
- 0
Quick answer
dimethyl fumarate (DIMHERITY) is an FDA-listed pharmaceutical active ingredient. Associated with S.A.. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN dimethyl fumarate
Brand DIMHERITY
Route ORAL
Formulation CAPSULE, DELAYED RELEASE
ATC code L04AX07
Originator S.A.
Related patents
Search patents →Frequently asked questions
What is dimethyl fumarate?
dimethyl fumarate (DIMHERITY) is an FDA-listed pharmaceutical active ingredient. Associated with S.A.. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for dimethyl fumarate?
DIMHERITY is a marketed brand name for dimethyl fumarate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dimethyl fumarate?
dimethyl fumarate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.